http://rdf.ncbi.nlm.nih.gov/pubchem/patent/FR-2884423-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7ab889da9159642462c628ff0479eac8 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-688 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-685 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-60 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-6615 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-56 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-60 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-00 |
| filingDate | 2005-06-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_120c2425b26b48ec67f501e93431983d |
| publicationDate | 2006-10-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | FR-2884423-A1 |
| titleOfInvention | USE OF LECITHIN AS A MEDICINAL PRODUCT IN THE TREATMENT OF PSORIASIS |
| abstract | The present invention relates to the use of lecithin or a lecithin-rich extract for the preparation of a pharmaceutical composition useful in the prevention and therapeutic treatment of new or old dermatoses, in particular psoriasis. Therapeutic compositions comprising lecithin or a lecithin-rich extract are also object of the present invention. According to an advantageous characteristic of the present invention, the phospholipids composing lecithin are esterified by omega-3 polyunsaturated fatty acids, in particular docosahexaenoic acid (DHA), eicosapentaenoic acid (EPA), docosapentaenoic acid (DPA) or an alkylglycerol.Lecithin may be a "marine lecithin" that is to say it is extracted from a marine organism selected from fish, shrimp, krill, zooplankton, algae, phytoplankton or a mixture thereof, the advantage of which is that its phospholipids, especially the phosphatidylcholine, are naturally esterified by omega-3 fatty acids, and essentially by DHA and EPA. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113995763-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113995763-B |
| priorityDate | 2005-04-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 33.